129 related articles for article (PubMed ID: 5660920)
1. Effects of varying boron-10 dose, thermal neutron fluence and reactor employed on results of neutron capture therapy of a transplantable mouse neoplasm.
Farr LE; Konikowski T
Int J Appl Radiat Isot; 1968 May; 19(5):459-70. PubMed ID: 5660920
[No Abstract] [Full Text] [Related]
2. Long range effects of neutron capture therapy of cancer in mice--II. Dose effect.
Farr LE; Konikowski T
Int J Nucl Med Biol; 1978 Mar; 5(1):3-10. PubMed ID: 659058
[No Abstract] [Full Text] [Related]
3. Investigation of neutron beams for the realization of boron neutron capture therapy.
Csom G; Zsolnay EM; Szondi EJ
Basic Life Sci; 1990; 54():141-51. PubMed ID: 2268235
[TBL] [Abstract][Full Text] [Related]
4. Biomedical irradiation system for boron neutron capture therapy at the Kyoto University Reactor.
Kobayashi T; Kanda K; Ujeno Y; Ishida MR
Basic Life Sci; 1990; 54():321-39. PubMed ID: 2176458
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium as a neutron capture therapy agent.
Shih JL; Brugger RM
Med Phys; 1992; 19(3):733-44. PubMed ID: 1508113
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of boronated tetracycline antibiotic derivatives (T 2 B 2 ) as the boron-10 carrier in neutron capture therapy.
Gillchriest WC; Shaw DH
Oncology; 1973; 27(2):97-104. PubMed ID: 4701584
[No Abstract] [Full Text] [Related]
7. Effect of neutron capture irradiation upon malignant brain tumors in mice.
Entzian W; Soloway AH; Raju R; Sweet WH; Brownell GL
Acta Radiol Ther Phys Biol; 1966; 5():95-100. PubMed ID: 6005657
[No Abstract] [Full Text] [Related]
8. [Accumulation of carborane-series compounds in animal tissues during neutron-capture therapy].
Spryshkova RA; Brattsev VA; Sherman TL; Stanko VI
Med Radiol (Mosk); 1981 Jul; 26(7):51-5. PubMed ID: 7289807
[No Abstract] [Full Text] [Related]
9. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
[TBL] [Abstract][Full Text] [Related]
10. Progress towards boron neutron capture therapy at the High Flux Reactor Petten.
Moss RL
Basic Life Sci; 1990; 54():169-83. PubMed ID: 2268238
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system.
Nakamura S; Imamichi S; Masumoto K; Ito M; Wakita A; Okamoto H; Nishioka S; Iijima K; Kobayashi K; Abe Y; Igaki H; Kurita K; Nishio T; Masutani M; Itami J
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):821-831. PubMed ID: 29225308
[TBL] [Abstract][Full Text] [Related]
12. Transplantable mouse neoplasm control by neutron capture therapy.
Farr LE; Konikowski T
Nature; 1967 Jul; 215(5100):550-2. PubMed ID: 6057936
[No Abstract] [Full Text] [Related]
13. In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.
Tilly N; Olsson P; Hartman T; Coderre J; Makar M; Malmquist J; Sjöberg S; Pettersson J; Carlsson J; Glimelius B
Radiother Oncol; 1996 Jan; 38(1):41-50. PubMed ID: 8850425
[TBL] [Abstract][Full Text] [Related]
14. Transport calculations of the influence of physical factors on depth-dose distributions in boron neutron capture therapy.
Matsumoto T
Phys Med Biol; 1990 Jul; 35(7):971-8. PubMed ID: 2117293
[TBL] [Abstract][Full Text] [Related]
15. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz.
Schmitz T; Blaickner M; Schütz C; Wiehl N; Kratz JV; Bassler N; Holzscheiter MH; Palmans H; Sharpe P; Otto G; Hampel G
Acta Oncol; 2010 Oct; 49(7):1165-9. PubMed ID: 20831509
[TBL] [Abstract][Full Text] [Related]
16. [Use of dimercaptocarborane derivatives in neutron capture therapy].
Spryshkova RA; Bratsev VA; Shabalkin IP
Med Radiol (Mosk); 1980 Nov; 25(11):46-50. PubMed ID: 7442488
[No Abstract] [Full Text] [Related]
17. Calibration of the borated ion chamber at NIST reactor thermal column.
Wang Z; Hertel NE; Lennox A
Radiat Prot Dosimetry; 2007; 126(1-4):626-30. PubMed ID: 17525059
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091
[TBL] [Abstract][Full Text] [Related]
19. Dose monitoring for boron neutron capture therapy using a reactor-based epithermal neutron beam.
Raaijmakers CP; Nottelman EL; Konijnenberg MW; Mijnheer BJ
Phys Med Biol; 1996 Dec; 41(12):2789-97. PubMed ID: 8971969
[TBL] [Abstract][Full Text] [Related]
20. RBEs of nuclear reactor beams and thermal neutrons in responses of B-16 melanoma.
Ujeno Y; Takimoto K; Kanda K; Kobayashi T; Ono K
Strahlentherapie; 1981 Oct; 157(10):682-4. PubMed ID: 7303025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
